Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients

Abstract

Rosiglitazone treatment of nondiabetic hypertensive patients improves insulin sensitivity, reduces systolic and diastolic blood pressure, and induces favorable changes in markers of cardiovascular risk. Insulin sensitizers may provide cardiovascular benefits when used in the treatment of patients with hypertension.